Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion

Business

Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion

Mon, Sep 22, 2025 0 Comments

Audio By Carbonatix

(Reuters) -Pfizer said on Monday it would acquire weight-loss drug developer Metsera for up to $4.9 billion to secure its position in the lucrative obesity treatment market.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)

Previous Exclusive-Bezos-backed renewables alliance targets $7.5 billion for developing countries

Next CVS to expand program aimed at reducing hospital readmissions for Medicare members

Salem News Channel | Today

More Business Headlines

Other News to Consider

Follow SRNNews.com

on Facebook

@SRNNews

Subscribe to our Newsletters RSS Feeds

Salem Media, our partners, and affiliates use cookies and similar technologies to enhance your browsing experience, analyze site traffic, personalize site content, and deliver relevant video recommendations. By using this website and continuing to navigate, you consent to our use of such technologies and the sharing of video viewing activity with third-party partners in accordance with the Video Privacy Protection Act and other privacy laws. Privacy Policy

X CLOSE

Email to a Friend

Pfizer to buy weight-loss drug developer Metsera for up to $4.9 billion

(Reuters) -Pfizer said on Monday it would acquire weight-loss drug developer Metsera for up to $4.9 billion to secure its position in the lucrative obesity treatment market. (Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)

X close